ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

BRMP Projects Priority Rated

April 11, 1980

Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday

July 6, 2012

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979